Company / Shares Outstanding
Editas Medicine, Inc. Shares Outstanding History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
82.7M
FY2025
5-year range
62.6M / 82.7M
FY2021-FY2025
Trend
+1.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 7 consecutive years, from 44507960.00 in FY2018 to 82734696.00 in FY2025.
Based on SEC 10-K filings.
82734696.00 in FY2025 with a 5-year CAGR of +8.8%.
Increased from 68847382.00 to 82734696.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +6.5%
- 5-Year CAGR
- +8.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- Editas Medicine, Inc.'s shares outstanding has grown for 7 consecutive years.
- In FY2025, shares outstanding increased 1.2% year-over-year.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 82.7M | +1.2% |
| FY2024 | 81.8M | +18.8% |
| FY2023 | 68.8M | +0.6% |
| FY2022 | 68.4M | +9.4% |
| FY2021 | 62.6M | +15.1% |
| FY2020 | 54.4M | +11.5% |
| FY2019 | 48.8M | +9.6% |
| FY2018 | 44.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026